Table 1:

Baseline Characteristics and 1-Year Outcomes

Variable	TAVR (N = 179)	Medical Therapy (N = 179)
Age, years ± SD	83.1 ± 8.6	83.2 ± 8.3
Male sex, %	45.8	46.9
White race, %	92.2	90.5
COPD, %	41.3	52.5
Cerebrovascular Disease, %	27.4	27.4
STS Mortality Risk Score ± SD	11.2 ± 5.8	11.9 ± 4.8
KCCQ-OS
Baseline ± SD	36.2 ± 20.5	34.4 ± 20.1
1-Month ± SD	61.6 ± 26.2	49.2 ± 24.3
6-Month ± SD	70.7 ± 23.0	50.5 ± 26.1
12-Month ± SD	69.4 ± 25.4	47.0 ± 24.6
1-Year Survival (95% CI)	0.69 (0.63, 0.76)	0.49 (0.42, 0.57)

SD = standard deviation; STS = Society of Thoracic Surgeons; COPD = chronic obstructive pulmonary disease; CI = confidence interval.